Author

Laurent Gros

InsermORCID 0000-0001-5116-2980Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

David PépiniD· 2 shared Estelle Tromelin· 2 shared Henri‐Alexandre MichaudiD· 2 shared Julien Roche-PrellezoiD· 2 shared Maeva Y. ChauviniD· 2 shared Marie-Charlotte MeinsohniD· 2 shared Nathalie BonnefoyiD· 2 shared Virginie LafontiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

David PépinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedJul 1, 2026

Cancer-Associated Mesothelial Cells Drive Immune Escape and Therapy Resistance in Ovarian Cancer

Maeva Y. Chauvin, Julien Roche-Prellezo, Virginie Lafont…·David Pépin

This study identifies cancer-associated mesothelial cells (CAMCs) as drivers of immune escape and therapy resistance in ovarian cancer by altering immune cell infiltration and function.

DOI 10.1136/jitc-2026-015236

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewedSep 30, 2025

FSTL3 is a biomarker of poor prognosis and is associated with immunotherapy resistance in ovarian cancer.

Maeva Y. Chauvin, Estelle Tromelin, Julien Roche-Prellezo…·David Pépin

This study identifies FSTL3 as a biomarker of poor prognosis and immunotherapy resistance in ovarian cancer, showing its role in promoting a mesenchymal phenotype and immunosuppressive microenvironment.

4 citations

mouseproteomics

𝕏 PostBluesky